References
- Pusztai L, Siddik ZH, Mills GB, Bast Jr RC: Physiologic and pathologic drug resistance in ovarian carcinoma: an hypothesis based on a clonal progression model. Acta Oncol 1998; 37: 629–40.
- Beck WT, Dalton WS. Mechanisms of drug resistance. In: De Vita Jr VT, Hellman S, Rosenberg SA, eds. Cancer. Principles & practice of oncology. Philadelphia, New York: Lippincott-Raven, 1997: 498–512.
- Karran P, Hampson R. Genomic instability and tolerance to alkylating agents. Cancer Surv 1996; 28: 69–85.
- Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Clin Cancer Res 1998; 4: 1–6.
- Dong Z, Radinsky R, Fan D, et al. Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells. J Natl Cancer Inst 1994; 86: 913–20.